Your browser is no longer supported. Please, upgrade your browser.
Settings
MNK Mallinckrodt plc daily Stock Chart
MNK [NYSE]
Mallinckrodt plc
Index- P/E- EPS (ttm)-41.51 Insider Own1.50% Shs Outstand84.22M Perf Week-23.16%
Market Cap343.62M Forward P/E0.53 EPS next Y7.67 Insider Trans0.75% Shs Float81.61M Perf Month-43.49%
Income-3458.00M PEG- EPS next Q2.02 Inst Own- Short Float44.82% Perf Quarter-72.21%
Sales3.25B P/S0.11 EPS this Y-421.90% Inst Trans4.05% Short Ratio9.50 Perf Half Y-81.29%
Book/sh36.70 P/B0.11 EPS next Y-10.00% ROA-29.60% Target Price10.00 Perf Year-87.42%
Cash/sh2.86 P/C1.43 EPS next 5Y9.17% ROE-88.20% 52W Range3.85 - 36.65 Perf YTD-74.18%
Dividend- P/FCF0.47 EPS past 5Y4.35% ROI-36.70% 52W High-88.02% Beta2.41
Dividend %- Quick Ratio0.60 Sales past 5Y14.30% Gross Margin44.70% 52W Low14.03% ATR0.61
Employees3700 Current Ratio0.80 Sales Q/Q-0.30% Oper. Margin- RSI (14)26.19 Volatility13.13% 10.72%
OptionableYes Debt/Eq1.80 EPS Q/Q-115.60% Profit Margin- Rel Volume1.66 Prev Close4.08
ShortableYes LT Debt/Eq1.57 EarningsAug 06 BMO Payout- Avg Volume3.85M Price4.39
Recom3.00 SMA20-26.29% SMA50-42.58% SMA200-74.54% Volume1,374,250 Change7.60%
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Nov-08-17Downgrade Goldman Buy → Neutral
Nov-08-17Downgrade Barclays Overweight → Equal Weight $65 → $23
Nov-07-17Downgrade Deutsche Bank Buy → Hold $44 → $28
Aug-19-19 10:15AM  Karyopharm Therapeutics Inc. (KPTI), Mallinckrodt plc (MNK) & National General Holdings Corp. (NGHC) - Bronstein, Gewirtz & Grossman, LLC - Class Action Reminder ACCESSWIRE +7.60%
Aug-18-19 07:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of INS, MNK and EVH ACCESSWIRE
07:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm GlobeNewswire
Aug-16-19 03:45PM  CLASS ACTION UPDATE for LB, EGBN and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:52PM  Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Mallinckrodt plc MNK GlobeNewswire
12:34PM  Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock? Zacks
10:47AM  Karyopharm Therapeutics Inc. (KPTI), Mallinckrodt plc (MNK) & National General Holdings Corp. (NGHC) - Class Action - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
07:26AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm ACCESSWIRE
Aug-15-19 07:15PM  ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Mallinckrodt plc Investors of Important Deadline in Securities Class Action MNK GlobeNewswire -11.85%
04:56PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
04:48PM  Here's Why Mallinckrodt Dropped 12% Today Motley Fool
12:42PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc Business Wire
10:19AM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm Newsfile
09:18AM  CLASS ACTION UPDATE for MNK, JE, GTT and EVH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:39AM  Mallinckrodt Confirms Positive Late-Stage Readout For Hepatorenal Syndrome Drug Benzinga
06:59AM  Mallinckrodt's stock shoots up after positive phase 3 trial data on HRS-1 treatment MarketWatch
06:45AM  Mallinckrodt Announces Positive Top-Line Results from its Pivotal Phase 3 CONFIRM Trial of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) PR Newswire
Aug-14-19 12:43PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc Business Wire
10:46AM  Karyopharm Therapeutics Inc. (KPTI), Mallinckrodt plc (MNK) & National General Holdings Corp. (NGHC) - Class Action Update - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:45AM  Is Mallinckrodt (MNK) a Profitable Pick for Value Investors? Zacks
Aug-13-19 10:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK ACCESSWIRE
09:30PM  SHAREHOLDER DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
05:00PM  Mallinckrodt Announces Publication of Results of Phase 1b Clinical Trial of StrataGraft® Regenerative Tissue in Burns PR Newswire
03:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm ACCESSWIRE
11:53AM  Mallinckrodt Enrolls First Patient in Liver Disease Study Zacks
10:45AM  SHAREHOLDER ALERT: MNK JE CURLF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:15AM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Aug-12-19 06:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MNK, GTT and TWOU ACCESSWIRE -8.76%
06:00PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
03:15PM  CLASS ACTION UPDATE for VERB, MNK and CARB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
02:16PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
12:10PM  Bristol-Myers Squibb Stock Has Upside But Mind the Risks InvestorPlace
11:20AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ZUO, MNK and TWOU ACCESSWIRE
10:46AM  Karyopharm Therapeutics Inc. (KPTI), Mallinckrodt plc (MNK) & National General Holdings Corp. (NGHC) - Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
06:45AM  First Patient Enrolled in Mallinckrodt's Phase 2a Study of Investigational Drug MNK-6106 in Hepatic Cirrhosis and Chronic Hepatic Encephalopathy (HE) PR Newswire
Aug-11-19 07:17PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against L Brands, National General, Mallinckrodt, and Oasmia and Encourages Investors to Contact the Firm GlobeNewswire
10:26AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VNTR, MNK and CARB ACCESSWIRE
Aug-10-19 12:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
Aug-09-19 07:25PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MMM, MNK and CAH ACCESSWIRE -13.66%
06:00PM  ROSEN, A TOP RANKED LAW FIRM, Reminds Mallinckrodt plc Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm MNK Business Wire
04:38PM  CLASS ACTION UPDATE for OMCL, MNK and EVH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:00PM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: September 24, 2019 GlobeNewswire
10:35AM  SHAREHOLDER ALERT: FRED NGHC MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
Aug-08-19 07:10PM  CLASS ACTION UPDATE for RLGY, MNK and CAH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE +9.04%
05:30PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc Investors (MNK) Business Wire
04:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of VNTR, NGHC and MNK ACCESSWIRE
03:00PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc Investors (MNK) Business Wire
09:24AM  CLASS ACTION UPDATE for VNTR, MMM, RBGLY and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Aug-07-19 09:30PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Mallinckrodt plc Investors (MNK) Business Wire
08:05PM  CLASS ACTION UPDATE for DBD, MNK and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
07:13PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Mallinckrodt plc Investors (MNK) Business Wire
06:20PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm ACCESSWIRE
05:34PM  Mallinckrodt suspends plans for generic drug spinoff American City Business Journals
02:00PM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PVTL, LB and MNK ACCESSWIRE
01:37PM  Mallinckrodt (MNK) Q2 Earnings Beat, Generics Spin-off on Hold Zacks
01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK ACCESSWIRE
10:45AM  SHAREHOLDER ALERT: DBD INS MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
06:15AM  Opioid Uncertainties Grew and Investors Headed for the Exits Barrons.com
Aug-06-19 09:24PM  Mallinckrodt (MNK) Q2 2019 Earnings Call Transcript Motley Fool -12.04%
06:24PM  Edited Transcript of MNK earnings conference call or presentation 6-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
04:19PM  Why Mallinckrodt Stock Is Dropping Today Motley Fool
04:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BUD, MNK and JE ACCESSWIRE
03:36PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm GlobeNewswire
01:02PM  The Opioid Crisis Cant Be Engineered Away Bloomberg
11:41AM  3 Big Losers on a Winning Day - And the 3 Different Ways I'd Play Them TheStreet.com
10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of EGBN, MNK and CURLF ACCESSWIRE
10:16AM  Company News For Aug 6, 2019 Zacks
09:41AM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
08:56AM  Mallinckrodt Stock Is Swinging Wildly Following Positive Earnings Barrons.com
07:30AM  Mallinckrodt (MNK) Q2 Earnings Beat Estimates Zacks
07:24AM  Mallinckrodt Reports Q2 Earnings Beat Benzinga
06:45AM  UPDATE 1-Mallinckrodt puts on hold generics spinoff as opioid litigation drags Reuters
06:15AM  Mallinckrodt suspends plans to spin off generics unit Reuters
06:00AM  Mallinckrodt plc Reports Strong Results in Second Quarter 2019, Raises Adjusted EPS Guidance for 2019, and Announces Suspension of Specialty Generics Spin-off PR Newswire
Aug-05-19 09:55PM  SHAREHOLDER ALERT: NGHC MNK CURLF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, 3M Company, and Aclaris Therapeutics and Encourages Investors to Contact the Firm GlobeNewswire
06:09PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline MNK GlobeNewswire
05:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PVTL, TUSK and MNK ACCESSWIRE
03:15PM  ONGOING SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
10:50AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ASNA, NGHC and MNK ACCESSWIRE
09:59AM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: September 24, 2019 ACCESSWIRE
Aug-04-19 10:46AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PYX, EQT and MNK ACCESSWIRE
Aug-02-19 08:05PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
06:30PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FRED, MNK and CARB ACCESSWIRE
05:00PM  ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt plc; Encourages Investors with Losses in Excess of $100K to Contact the Firm MNK GlobeNewswire
04:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK ACCESSWIRE
03:30PM  CLASS ACTION UPDATE for HRTX, EROS and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM  SHAREHOLDER ALERT - Mallinckrodt plc (MNK) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: September 24, 2019 GlobeNewswire
03:00PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm ACCESSWIRE
06:55AM  Mallinckrodt to Present at Wells Fargo Securities 2019 Healthcare Conference PR Newswire
Aug-01-19 03:15PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of RBGLY, LB and MNK ACCESSWIRE
01:15PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mallinckrodt plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:15PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Mallinckrodt plc To Contact The Firm ACCESSWIRE
12:30PM  CLASS ACTION UPDATE for NFLX, LB and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:52AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Mallinckrodt plc MNK GlobeNewswire
Jul-31-19 08:40PM  SHAREHOLDER ALERT: FRED NFLX MNK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:36PM  ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt plc; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MNK PR Newswire
03:45PM  CLASS ACTION UPDATE for NFLX, NGHC and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with the Washington University School of Medicine and Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM
Trudeau MarkPresident and CEOMar 05Buy22.651,00022,650229,252Mar 06 08:18 AM
Trudeau MarkPresident and CEODec 10Buy20.181,00020,180236,254Dec 11 08:30 AM